Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives
Pharmaceutics · 27.11.2024 · 16 (12) · 1527
DOI: 10.3390/pharmaceutics16121527 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 27.11.2024. Verfasst von Umme Hani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: king khalid university.
Abstract (Originalsprache)
Cancer, the most common condition worldwide, ranks second in terms of the number of human deaths, surpassing cardiovascular diseases. Uncontrolled cell multiplication and resistance to cell death are the traditional features of cancer. The myriad of treatment options include surgery, chemotherapy, radiotherapy, and immunotherapy to treat this disease. Conventional chemotherapy drug delivery suffers from issues such as the risk of damage to benign cells, which can cause toxicity, and a few tumor cells withstand apoptosis, thereby increasing the likelihood of developing tolerance. The side effects of cancer chemotherapy are often more pronounced than its benefits. Regarding drugs used in cancer chemotherapy, their bioavailability and stability in the tumor microenvironment are the most important issues that need immediate addressing. Hence, an effective and reliable drug delivery system through which both rapid and precise targeting of treatment can be achieved is urgently needed. In this work, we discuss the development of various nanobased carriers in the advancement of cancer therapy—their properties, the potential of polymers for drug delivery, and recent advances in formulations. Additionally, we discuss the use of tumor metabolism-rewriting nanomedicines in strengthening antitumor immune responses and mRNA-based nanotherapeutics in inhibiting tumor progression. We also examine several issues, such as nanotoxicological studies, including their distribution, pharmacokinetics, and toxicology. Although significant attention is being given to nanotechnology, equal attention is needed in laboratories that produce nanomedicines so that they can record themselves in clinical trials. Furthermore, these medicines in clinical trials display overwhelming results with reduced side effects, as well as their ability to modify the dose of the drug.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
- Department of Pharmaceutics, The Oxford College of Pharmacy, Hongsandra, Bengaluru 560068, India.
- Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSS AHER), Mysuru 570015, India.
- Department of Pharmaceutical Sciences, School of Applied Sciences and Technology, University of Kashmir, Srinagar 190006, India.
- Department of Cell Biology and Molecular Genetics, Sri Devraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research, Kolar 563103, India.
ORCID-Profile: Umme Hani, Vikram T Choudhary, Mohammed Ghazwani, Shahid Ud Din Wani, Sathishbabu Paranthaman
Förderung
- king khalid university
Zitieren
APA
Hani, U., Choudhary, V. T., Ghazwani, M., Alghazwani, Y., Osmani, R. A. M., Kulkarni, G. S., Shivakumar, H. G., Wani, S. U. D., & Paranthaman, S. (2024). Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives. Pharmaceutics, 16(12), 1527. https://doi.org/10.3390/pharmaceutics16121527
Vancouver
Hani U, Choudhary VT, Ghazwani M, Alghazwani Y, Osmani RAM, Kulkarni GS, et al. Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives. Pharmaceutics. 2024;16(12):1527. doi:10.3390/pharmaceutics16121527
BibTeX
@article{Hani2024,
author = {Hani, Umme and Choudhary, Vikram T and Ghazwani, Mohammed and Alghazwani, Yahia and Osmani, Riyaz Ali M and Kulkarni, Gururaj S and Shivakumar, Hosakote G and Wani, Shahid Ud Din and Paranthaman, Sathishbabu},
title = {Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {12},
pages = {1527},
doi = {10.3390/pharmaceutics16121527}
}
EUVIMED